NCT03426267 - Evaluation of Efficacy and Safety of SDN-037 | Biotech Hunter

Enrollment

325

Participants

Timeline

Start Date

September 28, 2018

Primary Completion Date

March 5, 2020

Study Completion Date

March 5, 2020

Conditions

Inflammation and Pain Associated With Ocular Surgery

Interventions

DRUG

SDN-037

twice daily

DRUG

Placebo

twice daily

Trial Locations (19)

12603

SPARC Site 03, Poughkeepsie

27101

SPARC Site 04, Winston-Salem

32204

SPARC Site 16, Jacksonville

33067

SPARC Site 06, Coral Springs

33143

SPARC Site 07, Miami

33901

SPARC Site 18, Fort Myers

42001

SPARC Site 15, Paducah

49085

SPARC Site 05, Saint Joseph

58103

SPARC Site 17, Fargo

72704

SPARC site 01, Fayetteville

78572

SPARC Site 2, Mission

78731

SPARC Site 19, Austin

80919

SPARC Site 08, Colorado Springs

85208

SPARC Site 14, Mesa

85224

SPARC Site 13, Chandler

85351

SPARC Site 12, Sun City

86301

SPARC Site 11, Prescott

89052

SPARC Site 09, Henderson

93110

SPARC Site 10, Santa Barbara

All Listed Sponsors

lead

Sun Pharma Advanced Research Company Limited

INDUSTRY